INS and Insulin resistance: To verify the role of p-ERK 1/2 in insulin resistance, researchers have inhibited p-ERK 1/2 activity by gene editing, shRNA, or specific inhibitors and found that this could improve insulin sensitivity, thus providing new strategies for the treatment of insulin resistance and type 2 diabetes.